ISDA

Deposition Date 2013-10-21

Release Date 2014-02-12

Last Version Date 2024-10-16

Entry Detail

PDB ID:

4NA9

Keywords:

HYDROLASE/HYDROLASE INHIBITOR

Title:

Factor VIIa in complex with the inhibitor 3'-amino-5'-[(2s,4r)-6-carbamimidoyl-4-phenyl-1,2,3,4-tetrahydroquinolin-2-yl]biphenyl-2-carboxylic acid

Biological Source:

Source Organism:

Homo sapiens (Taxon ID: 9606)

Host Organism:

Cricetinae

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.24 Å

R-Value Free:

0.24

R-Value Work:

0.22

R-Value Observed:

0.22

Space Group:

P 41 21 2

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:Coagulation factor VII heavy chain
Gene (Uniprot):F7
Chain IDs:A (auth: H)
Chain Length:254
Number of Molecules:1
Biological Source:Homo sapiens

UniProt ID:P08709 Pfam ID:PF00089, PF14670 EC:3.4.21.21

Protein Blast

Polymer Type:polypeptide(L)
Molecule:Coagulation factor VII light chain
Gene (Uniprot):F7
Chain IDs:B (auth: L)
Chain Length:55
Number of Molecules:1
Biological Source:Homo sapiens

UniProt ID:P08709 Pfam ID:PF00089, PF14670 EC:3.4.21.21

Ligand Molecules

1T7

Primary Citation

Tetrahydroquinoline Derivatives as Potent and Selective Factor XIa Inhibitors.

Quan, M.L, Wong, P.C, Wang, C, Woerner, F, Smallheer, J.M, Barbera, F.A, Bozarth, J.M, Brown, R.L, Harpel, M.R, Luettgen, J.M, Morin, P.E, Peterson, T, Ramamurthy, V, Rendina, A.R, Rossi, K.A, Watson, C.A, Wei, A, Zhang, G, Seiffert, D, Wexler, R.R.Show

J.Med.Chem. 57 955 969 (2014)

PMID: 24405333 DOI: 10.1021/jm401670x

Abstact

Antithrombotic agents that are inhibitors of factor XIa (FXIa) have the potential to demonstrate robust efficacy with a low bleeding risk profile. Herein, we describe a series of tetrahydroquinoline (THQ) derivatives as FXIa inhibitors. Compound 1 was identified as a potent and selective tool compound for proof of concept studies. It exhibited excellent antithrombotic efficacy in rabbit thrombosis models and did not prolong bleeding times. This demonstrates proof of concept for the FXIa mechanism in animal models with a reversible, small molecule inhibitor.

Legend

Protein

Chemical

Disease

Primary Citation of related structures